Nuformix Plc (GB:NFX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Nuformix Plc confirms its total voting rights, following the issuance of new shares, with a total of 1,419,309,368 ordinary shares in circulation, each holding one vote. This information is crucial for shareholders to calculate their notification requirements under FCA rules. Nuformix, a pharmaceutical company focusing on fibrosis and oncology, aims to innovate through drug repurposing, offering new commercial opportunities.
For further insights into GB:NFX stock, check out TipRanks’ Stock Analysis page.
